2011
DOI: 10.1016/j.ejmech.2011.07.043
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and anticonvulsant properties of new acetamide derivatives of phthalimide, and its saturated cyclohexane and norbornene analogs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
28
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 53 publications
(29 citation statements)
references
References 30 publications
0
28
0
Order By: Relevance
“…Likewise, nine substances 5, 6, 7, 10, 11, 15, 17, 19, and 28 were effective only in the scPTZ test. Derivatives 5,7,9,11,12,13,15,17,19, and 28 showed protection at the dose of 100 mg/kg after 4 h. It is a better protection at thse same time point than the result of ethosuximide, recognized as the model antiepileptic drug effective in the scPTZ test. Especially interesting seem to be compounds 11 and 12, which revealed activity at the dose of 100 mg/kg not only after 4 h, but also after 0.5 h. The other compounds have demonstrated protection at the dose of 300 mg/kg after 4 h (6 and 10), and 0.5 h (compound 9).…”
Section: Pharmacologymentioning
confidence: 86%
See 3 more Smart Citations
“…Likewise, nine substances 5, 6, 7, 10, 11, 15, 17, 19, and 28 were effective only in the scPTZ test. Derivatives 5,7,9,11,12,13,15,17,19, and 28 showed protection at the dose of 100 mg/kg after 4 h. It is a better protection at thse same time point than the result of ethosuximide, recognized as the model antiepileptic drug effective in the scPTZ test. Especially interesting seem to be compounds 11 and 12, which revealed activity at the dose of 100 mg/kg not only after 4 h, but also after 0.5 h. The other compounds have demonstrated protection at the dose of 300 mg/kg after 4 h (6 and 10), and 0.5 h (compound 9).…”
Section: Pharmacologymentioning
confidence: 86%
“…Compounds 5,7,11,12,13,15, and 17, as well as ethosuximide and valproic acid compared with the vehicle-treated group, prolonged in a dose-dependent manner the latency time to first seizure episode. Compounds 5,7,11,12,13, and 17 at doses 100 and 150 mg/kg significantly prolonged latency time to the first seizure episode by 99-142% and 119-176%, respectively. Compound 15 at the dose of 150 mg/kg lengthened latency time to the first seizure episode by 128%, in a statistically significant manner, whereas reference compounds significantly prolonged latency time to the first seizure episode starting at the dose of 120 mg/kg (ethosuximide) or 250 mg/kg (valproic acid).…”
Section: Pharmacologymentioning
confidence: 99%
See 2 more Smart Citations
“…Furthermore, many literatures have investigated the phthalimide derivatives due to their diverse range of biological activities such as antimicrobial [2][3][4][5], antiviral [6,7], anticancer [8,9], anti-inflammatory [10,11],antiepileptic [12,13], antihyperlipidimic [14,15], antihyperglycemic [16], anxiolytic [17], etc.…”
Section: Introductionmentioning
confidence: 99%